CB Insights: Cannvalate’s Series A Round

Mar 21, 2019 | News

Cannvalate raised a round of funding on October 29, 2018.

Cannvalate is a medical cannabis company aiming to bring safe and effective cannabinoid-based products to the Australian market.

Please read the full article here.

Disclaimer: Cannvalate and its affiliates are not inducing anyone to use Medical Cannabis. Cannabis is a drug and may have negative side effects or interactions with other medications. Medicinal Cannabis doesn’t work for everyone. If you think Medicinal Cannabis is right for you, please check with our doctors. How Cannabis affects a person and is metabolised depends on many things including their condition, size, weight, age and health, dosage, other medications and tolerance. Other drugs, medications or supplements that are being taken can also interact with or be affected by Cannabis. Medical Cannabis in Australia is regulated by the Therapeutic Goods Administration and details about Cannabis as a scheduled drug can be found on their website. Please consult with your doctor to find out if Cannabis is right for you.